Literature DB >> 30925518

The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis.

Melinda Magyari1, Per Soelberg Sorensen.   

Abstract

PURPOSE OF REVIEW: This review provides a brief update of new research findings on the changing epidemiology, disease course, and prognosis of multiple sclerosis (MS). RECENT
FINDINGS: Evidence not only continues to support the female predominance in incidence and prevalence of the disease but also supports an increase in incidence of MS in geographic areas that were previously considered to be low incidence for the disease.
SUMMARY: An increased interest in population-based registries and databases will provide more valid epidemiological measures and observational studies conducted in well-defined study populations. Such studies are crucial for an accurate description of both changing prognosis of MS and differential characteristics of the various MS phenotypes.

Entities:  

Mesh:

Year:  2019        PMID: 30925518     DOI: 10.1097/WCO.0000000000000695

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  15 in total

1.  Autonomic nervous system: a key player in prodromal multiple sclerosis?

Authors:  Mario Habek; Magdalena Krbot Skorić
Journal:  Clin Auton Res       Date:  2020-03-11       Impact factor: 4.435

2.  Nitrosative stress parameters and the level of oxidized DNA bases in patients with multiple sclerosis.

Authors:  Vitalijs Borisovs; Jevgenijs Bodrenko; Jolanta Kalnina; Nikolajs Sjakste
Journal:  Metab Brain Dis       Date:  2021-08-21       Impact factor: 3.584

Review 3.  Caregiver Burden in Multiple Sclerosis: Recent Trends and Future Directions.

Authors:  Rebecca Maguire; Phil Maguire
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-22       Impact factor: 5.081

4.  Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome.

Authors:  Yang Zheng; Chun-Hong Shen; Sa Wang; Fan Yang; Meng-Ting Cai; Wei Fang; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Ther Adv Neurol Disord       Date:  2020-01-20       Impact factor: 6.570

Review 5.  Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.

Authors:  Angela Dziedzic; Joanna Saluk-Bijak; Elzbieta Miller; Michal Bijak
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

Review 6.  Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).

Authors:  Stanley L Cohan; Barry A Hendin; Anthony T Reder; Kyle Smoot; Robin Avila; Jason P Mendoza; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2021-07-06       Impact factor: 5.749

7.  The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model.

Authors:  Gabriele Di Sante; Susanna Amadio; Beatrice Sampaolese; Maria Elisabetta Clementi; Mariagrazia Valentini; Cinzia Volonté; Patrizia Casalbore; Francesco Ria; Fabrizio Michetti
Journal:  Cells       Date:  2020-03-18       Impact factor: 6.600

8.  S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis.

Authors:  Chiara Camponeschi; Maria De Carluccio; Susanna Amadio; Maria Elisabetta Clementi; Beatrice Sampaolese; Cinzia Volonté; Maria Tredicine; Vincenzo Romano Spica; Rosa Di Liddo; Francesco Ria; Fabrizio Michetti; Gabriele Di Sante
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

9.  Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France.

Authors:  Brigitte Gbaguidi; Francis Guillemin; Marc Soudant; Marc Debouverie; Guillaume Mathey; Jonathan Epstein
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

Review 10.  Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Authors:  Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.